tiprankstipranks
Hightide Therapeutics Inc (HK:2511)
:2511
Hong Kong Market
2511
Hightide Therapeutics Inc
RESEARCH TOOLSreports
Want to see HK:2511 full AI Analyst Report?

Hightide Therapeutics Inc (2511) Income Statement

1 Followers

Hightide Therapeutics Inc Income Statement

Last quarter (Q4 2025), Hightide Therapeutics Inc's total revenue was ¥0.00, a decrease of ― from the same quarter last year. In Q4, Hightide Therapeutics Inc's net income was ¥-122.57M. See Hightide Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Gross Profit
¥ 0.00¥ 0.00¥ -2.02M¥ -1.30M¥ -1.56M
Operating Expenses
¥ 217.78M¥ 444.75K¥ 454.37M¥ 229.56M¥ 128.33M
Depreciation and Amortization
¥ 0.00¥ 537.00¥ 2.02M¥ 1.30M¥ 276.00K
EBITDA
¥ -217.78M¥ -444.22K¥ -1.04B¥ -229.56M¥ -131.80M
Operating Income
¥ -217.78M¥ -444.75K¥ -456.39M¥ -226.08M¥ -132.08M
Other Income/Expenses
¥ -8.10M¥ 63.23K¥ -581.45M¥ 35.88M¥ -88.97M
Pretax Income
¥ -225.88M¥ -381.52K¥ -1.04B¥ -190.21M¥ -221.05M
Net Income
¥ -238.63M¥ -381.79K¥ -1.04B¥ -190.24M¥ -221.15M
Per Share Metrics
Basic EPS
¥ -0.49¥ -0.84¥ -4.00¥ -0.38¥ -0.42
Diluted EPS
¥ -0.49¥ -0.84¥ -4.00¥ -0.38¥ -0.42
Weighted Average Shares Outstanding
 479.74M 452.08K---
Weighted Average Shares Outstanding (Diluted)
 479.74M 452.08K---
Currency in CNY

Hightide Therapeutics Inc Earnings and Revenue History